Bioderma Sensibio Ar Tinted BB Cream 40ml

€17.50
IN STOCK ONLINE
SKU
1018667
Feefo logo
Sensibio AR BB Cream is the 1st skin-perfecting Anti-Redness treatment that reduces redness by regulating the biological factor responsible for vasodilation, protects from UV rays aggravating.... More details below
Sensibio AR BB Cream is the 1st skin-perfecting Anti-Redness treatment that reduces redness by regulating the biological factor responsible for vasodilation, protects from UV rays aggravating erythrosis, evens out the complexion and enhances radiance for flawless skin.
Its exclusive, innovative Rosactiv? patent directly acts on VEGF, one of the main factors responsible for the dilation and weakening of skin capillaries, sources of redness.
Enoxolone, allantoin and canola, a combination of intense soothing agents, instantly reduce heating sensations.
The D.A.F. (Dermatological Advanced Formulation) patented natural complex increases the skin''s tolerance threshold.
Glycerine and canola moisturise, strengthen the barrier function and provide real skin comfort.
Light-reflecting powders and pigments conceal redness, leave a matt, velvety finish and enhance the skin''s radiance.
More Information
Brand Bioderma
Product Type Face Cream

FREE Delivery within Ireland for orders over €39!

Orders are normally dispatched within 1-3 working days

Working days are Monday to Friday 8.30am to 5.00pm (excluding bank holidays), when you order at the weekend, your order will be entered into the processing que Monday morning.

Where possible we will try to adhere to, or even better, exceed these lead times. In the unlikely event that we cannot fulfil your order in the time frame promised we will contact you immediately to inform you of the reason for delay. 

Deliveries require a signature and cannot be left without one. Please keep this in mind with regard to your delivery address as selecting your home address while in work will result in a delay of your delivery.

For more information please see - Delivery and Returns

No reviews yet.